CIKAUTXO S COOP

Their core work

CIKAUTXO is a Basque industrial cooperative based in Berriatua — a region synonymous with precision manufacturing and the Mondragón cooperative tradition. The name itself ("kautxo" is Basque for rubber/latex) signals a likely background in polymer and elastomer manufacturing, which explains their involvement in two very different EU pilot-line projects: precision medical device components and bio-based chemical process scale-up. In both cases they appear as a specialist industrial partner contributing manufacturing or materials expertise rather than research leadership. Their participation in POSITION-II, a smart catheter pilot line with over 100 consortium members, and VIPRISCAR, an industrial process validation for bio-derived plastics precursors, confirms a pattern: they bring industrial fabrication capability to research-to-production transitions.

What they specialise in

How they've shifted over time

Both projects started in 2018, so there is no meaningful chronological shift to analyze — the entire H2020 portfolio is a single cohort. The early-period keywords are exclusively tied to interventional cardiology device types (IVUS, FFR, ICE, implantables), while the second project leaves no keywords at all, likely because VIPRISCAR was a chemistry/process project with little public keyword tagging. What can be said is that within a single year, CIKAUTXO joined two thematically unrelated consortia — precision medical devices and bio-based chemistry — which suggests their value to partners is a transferable manufacturing process capability rather than deep domain specialization in either field.

With only two projects both launched in 2018 and no subsequent H2020 participation, it is impossible to identify a directional trend — future collaborators should verify whether CIKAUTXO has pursued Horizon Europe projects since 2021.

How they like to work

CIKAUTXO has participated exclusively as a consortium partner, never as a project coordinator, across both recorded projects. Notably, those two projects generated 56 unique partner relationships across 13 countries, indicating participation in very large industrial pilot consortia rather than small research groups. This profile is typical of a manufacturing specialist that large research-led consortia recruit to provide production credibility and scale-up infrastructure — they are sought out, not organizing the initiative themselves.

Despite only two projects, CIKAUTXO has touched 56 distinct partners across 13 countries — a high network density that reflects the large consortium structures typical of BBI and ICT pilot-line projects. No geographic clustering is identifiable from available data.

What sets them apart

CIKAUTXO's core differentiation appears to be industrial manufacturing capability in a region (Basque Country) with deep engineering traditions — something research institutions cannot replicate and many consortia need to bridge the gap from lab prototype to pilot production. Their willingness to participate across two very different technology domains (medical devices and bio-based chemistry) in the same year suggests organizational flexibility and a process-agnostic manufacturing mindset. For consortium builders needing a credible industrial partner in Spain to satisfy geographic or SME-adjacent requirements, they represent a low-profile but practically useful node.

Highlights from their portfolio

• POSITION-II
  A large ECSEL Joint Undertaking pilot-line project for next-generation smart catheters covering IVUS, FFR, and ICE device families — CIKAUTXO's only funded project (EUR 111,827) and its most technically specific EU engagement.
• VIPRISCAR
  A Bio-Based Industries RIA project validating industrial-scale production of isosorbide bis(methyl carbonate), a sustainable plastics precursor — notable for its cross-sector distance from CIKAUTXO's medical device work.